A healthy recovery: The issue facing the pharma industry

Getting the sector back in shape

clock • 4 min read

Imagine you are a business owner and you are presented with an enormous gap in your market that needs filling and there is a dearth of competition.

But what if the products that would fill that gap are not only unprofitable, but become less valuable the more people use them? What would you do?  This is the issue facing the pharmaceutical industry, which the world depends on to provide the bedrock of modern healthcare - antibiotics. Investment in new antibiotics has slowed to the lowest rate in history, and big pharmaceutical companies have largely abandoned the field.  Modern healthcare systems are built on the ability to control infection, and our tools in that fight - antibiotics - were in crisis even before Covid-19 hit.  C...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on ESG

FE fundinfo's Matthias Breier: Is that investment fund sustainable? Let's check with the SDR
ESG

FE fundinfo's Matthias Breier: Is that investment fund sustainable? Let's check with the SDR

'SDR does go a long way'

Matthias Breier
clock 23 April 2024 • 3 min read
Earth Day 2024: Decarbonisation megatrend boosts prospects for European industrials
ESG

Earth Day 2024: Decarbonisation megatrend boosts prospects for European industrials

Cautious on investing in wind energy

Matthew Donen
clock 19 April 2024 • 4 min read
Holtara's Cristian Echavarria: A sustainable fund by any other name
ESG

Holtara's Cristian Echavarria: A sustainable fund by any other name

Likely outcomes of the consultation

Cristian Echavarria
clock 16 April 2024 • 4 min read
Trustpilot